## NKE: Nike, Inc. - XLY: Consumer Cyclical

### Executive Summary

No thesis match: MRS_20 2.8% below STRENGTH zone (4.0-10.0%); PEG 2.62 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($61.77)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 2
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. Is Lululemon's Brand Losing Its Heat?**
- Source: Finviz | 20251129T230500 | Neutral | Relevance: 68%
- Lululemon's brand strength is facing challenges due to declining comparable sales and increased price sensitivity in the U.S. consumer market. Intensified competition from brands like Alo Yoga and Vuori, coupled with some inconsistent product execution, puts pressure on its market position. Despite these challenges, strong international growth, particularly in China and Europe, and solid financial health, provide a foundation for potential recovery if the company refines its strategy in the U.S.

**2. Why Everyone Is Talking About Lululemon Stock Now**
- Source: Finviz | 20251129T100500 | Neutral | Relevance: 60%
- Lululemon stock is currently under scrutiny due to slowing growth in the U.S., mounting margin pressure from tariffs and higher import costs, and increased competition. While international markets remain strong, the company faces a critical juncture, needing to stabilize its U.S. business and navigate a challenging cost environment to maintain its long-term growth profile and brand strength. Investors are watching closely to see if management can execute effectively and reaccelerate momentum.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-10 | Telsey Advisory | $75 | $75 | 0% |
| 2025-12-10 | Guggenheim | $77 | $0 | 0% |
| 2025-12-09 | Citigroup | $70 | $74 | -5% |
| 2025-11-13 | Wells Fargo | $75 | $60 | +25% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-10 | Telsey Advisory | main | Market Perform |
| 2025-12-10 | Guggenheim | init | Buy |
| 2025-12-09 | Citigroup | main | Neutral |
| 2025-11-13 | Wells Fargo | up | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 1 ($1.00M) |
| Sells | 4 ($0.68M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 37.9% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 9.7% (+1.3%)
- Blackrock Inc.: 7.7% (-0.1%)
- State Street Corpora: 4.9% (-1.9%)
- Capital World Invest: 3.5% (+0.7%)
- JPMORGAN CHASE & CO: 2.7% (+72.1%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Momentum building: MRS_20 improving +3.6% over 5 days suggests accumulation.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 2.62 signals overvaluation risk, limited margin of safety. Forward P/E 25.8x attractive for 51% earnings growth. Quality metrics strong (ROE 21%). Balance sheet: strong liquidity (2.2x). Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $97.3B |
| Beta | 1.29 |
| 52W Range | $52.28 - $82.44 |
| Short Interest | 4.4% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.62 |
| Forward P/E | 25.8 |
| Current P/E | 38.8 |
| YoY Growth | 50.7% |
| EPS Direction | STABLE |

### Technicals

MRS_20 strengthening from -0.8% to 2.8% (+3.6% in 5 days), confirming momentum buildup. Below STRENGTH zone by 1.2pp (needs >4.0% for momentum thesis). MRS_5 at 1.9% confirms short-term momentum alignment. AM_20 at 3.9% shows strong absolute momentum above own 20MA. Below SMA200 (0.96x), long-term trend not supportive. MACD histogram positive (0.53), confirming momentum. RSI neutral at 54.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 2.79% (CS: 78) | Neutral |
| RSI_14 | 53.5 | Neutral |
| MACD Histogram | 0.53 | Bullish |
| vs SMA20 | 1.038x | Above |
| vs SMA50 | 0.983x | Below |
| vs SMA200 | 0.960x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $65.39
- **Stop Loss:** $61.77 (5.5% risk)
- **Target:** $69.01 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 276
- **Position Value:** $18,047.64
- **Portfolio %:** 18.05%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

### Earnings

**Next:** 2025-12-18 (Est: $0.37)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.27 | $0.49 | +84.5% |
| 2025Q2 | $0.12 | $0.14 | +13.5% |
| 2025Q1 | $0.28 | $0.54 | +94.9% |
| 2024Q4 | $0.63 | $0.78 | +23.3% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*